Evidence map›Paper›PMID 8413224›Full record

ArticleMolecular and cellular biology1993

Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase.

M L Samuels, M J Weber, J M Bishop, M McMahon

Abstract read
In one paragraph

Article in Molecular and cellular biology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. eIF5A-Independent Role of DHPS in p21International journal of molecular sciences · 2021
    Article
  6. Role of sex hormones in lung cancer.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  7. Mortalin (HSPA9) facilitatesScience signaling · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M L SamuelsDNAX Research Institute of Molecular and Cellular Biology, Palo Alto, California 94304.
M J Weber
J M Bishop
M McMahon

Funding

SIGNAL TRANSDUCTION BY TYROSINE KINASESR01CA039076 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI WEBER, MICHAEL J · 1985 to 2001
$488k
P42/MAP KINASE: STRUCTURE, FUNCTION AND REGULATIONR01GM047332 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI WEBER, MICHAEL J · 1992 to 2000
$227k
SIGNAL TRANSMISSION BY THE SRC ONCOGENER37CA039076 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI WEBER, MICHAEL J · 1989 to 1996
–
NCI NIH HHS CA 39076NCI NIH HHS CA 40042NIGMS NIH HHS GM 47332
6 · The paper itself

Abstract

We report a strategy for regulating the activity of a cytoplasmic signaling molecule, the protein kinase encoded by raf-1. Retroviruses encoding a gene fusion between an oncogenic form of human p74raf-1 and the hormone-binding domain of the human estrogen receptor (hrafER) were constructed. The fusion protein was nontransforming in the absence of estradiol but could be reversibly activated by the addition or removal of estradiol from the growth media. Activation of hrafER was accompanied in C7 3T3 cells by the rapid, protein synthesis-independent activation of both mitogen-activated protein (MAP) kinase kinase and p42/p44 MAP kinase and by phosphorylation of the resident p74raf-1 protein as demonstrated by decreased electrophoretic mobility. The phosphorylation of p74raf-1 had no effect on the kinase activity of the protein, indicating that mobility shift is an unreliable indicator of p74raf-1 enzymatic activity. Removal of estradiol from the growth media led to a rapid inactivation of the MAP kinase cascade. These results demonstrate that Raf-1 can activate the MAP kinase cascade in vivo, independent of other "upstream" signaling components. Parallel experiments performed with rat1a cells conditionally transformed by hrafER demonstrated activation of MAP kinase kinase in response to estradiol but no subsequent activation of p42/p44 MAP kinases or phosphorylation of p74raf-1. This result suggests that in rat1a cells, p42/p44 MAP kinase activation is not required for Raf-1-mediated oncogenic transformation. Estradiol-dependent activation of p42/p44 MAP kinases and phosphorylation of p74raf-1 was, however, observed in rat1a cells expressing hrafER when the cells were pretreated with okadaic acid. This result suggests that the level of protein phosphatase activity may play a crucial role in the regulation of the MAP kinase cascade. Our results provide the first example of a cytosolic signal transducer being harnessed by fusion to the hormone-binding domain of the estrogen receptor. This conditional system not only will aid the elucidation of the function of Raf-1 but also may be more broadly useful for the construction of conditional forms of other kinases and signaling molecules.

Indexed as

Cell Transformation, Neoplastic3T3 CellsAnimalsBase SequenceCloning, MolecularDNAEnzyme ActivationEstradiolEthers, CyclicHumansKineticsMiceMitogen-Activated Protein Kinase 1Molecular Sequence DataOkadaic AcidPhosphorylationDNAEstradiolEthers, CyclicMitogen-Activated Protein Kinase 1Okadaic AcidProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-rafReceptors, EstrogenTetradecanoylphorbol Acetate

Identifiers

PMID8413224
PMCPMC364683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.